Patent · US Active

Multispecific antibodies against CD40 and CD137

US11440966B2 · kind B2 · utility

2Cited by
2References
21Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 11, 2021
Grant dateSep 13, 2022
Priority date
Expiry dateJun 11, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Multispecific antibodies binding to human CD40 and human CD137, methods for preparing such multispecific antibodies, and methods of using such multispecific antibodies for therapeutic or other purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.